These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9464430)

  • 1. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
    Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
    Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scintimammography using Tc-99m tetrofosmin.
    Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
    Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
    Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
    Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
    Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
    Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99m-Tc-tetrofosmin scintigraphy for the evaluation of suspicious palpable and non-palpable breast lesions.
    Obwegeser R; Berghammer P; Muellauer-Ertl S; Kubista E; Sinzinger H
    Breast Cancer Res Treat; 2000 Aug; 62(3):253-8. PubMed ID: 11072790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
    Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
    Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy.
    Cwikla JB; Buscombe JR; Kelleher SM; Parbhoo SP; Thakrar DS; Hinton J; Deery AR; Crow J; Hilson AJ
    Clin Radiol; 1998 Apr; 53(4):274-80. PubMed ID: 9585043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
    Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
    Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology.
    Ortapamuk H; Ozmen MM; Ibis S; Naldöken S; Aksoy F
    Eur J Surg; 1999 Dec; 165(12):1147-53. PubMed ID: 10636548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of technetium-99m tetrofosmin scintimammography to detect breast cancer in mammographically dense breasts.
    Yang MD; Sun SS; Kao CH; Lin CC; Lee CC
    Cancer Invest; 2002; 20(4):518-23. PubMed ID: 12094547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
    Lumachi F; Zucchetta P; Marzola MC; Ferretti G; Povolato M; Paris MK; Brandes AA; Bui F
    Nucl Med Commun; 2002 Nov; 23(11):1073-8. PubMed ID: 12411835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy.
    Atasever T; Ozdemir A; Turkölmez S; Altinok M; Isik S
    Anticancer Res; 1999; 19(4C):3601-6. PubMed ID: 10629658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
    Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
    Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI.
    Akçay MN; Akin Y; Karabağ B; Ozcan O; Oren D
    Clin Nucl Med; 1997 Dec; 22(12):832-4. PubMed ID: 9408644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary use of scintimammography with 99m-Tc-MIBI to triple diagnostic procedure in palpable and non-palpable breast lesions.
    Wilczek B; Aspelin P; Boné B; Pegerfalk A; Frisell J; Danielsson R
    Acta Radiol; 2003 May; 44(3):288-93. PubMed ID: 12752000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99Tc(m)-tetrofosmin scintimammography for detecting breast cancer: a comparative study with 99Tc(m)-MIBI.
    Horne T; Pappo I; Cohen-Pour M; Baumer M; Orda R
    Nucl Med Commun; 2001 Jul; 22(7):807-11. PubMed ID: 11453054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of technetium-99m tetrofosmin mammoscintigraphy as compared to mammography for detecting and differentiating palpable breast masses of young Taiwanese women.
    Hoi YJ; Hsieh JF; Tsai SC; Sun SS; Kao CH
    Anticancer Res; 2000; 20(3B):2061-4. PubMed ID: 10928152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of scintimammography as an additional test to conventional mammography in detection of breast cancer].
    Cwikła JB; Buscombe JR; Kolasińska AD; Holloway B; Hilson AJ
    Ginekol Pol; 2003 May; 74(5):362-70. PubMed ID: 12931463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.